Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company focused on brain health, has announced it will host a live webcast on Wednesday, July 31, 2024, at 4:30 p.m. ET. The webcast will cover the company's second quarter 2024 financial results and provide updates on recent business activities. Investors and interested parties can access the webcast through the Investor page on Sage's website at investor.sagerx.com. A replay of the webcast will be available after the event and archived for up to 30 days.
- None.
- None.
The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240717928127/en/
Investor Contact
Ashley Kaplowitz
786-252-1419
ashley.kaplowitz@sagerx.com
Media Contact
Matthew Henson
917-930-7147
matthew.henson@sagerx.com
Source: Sage Therapeutics, Inc.
FAQ
When will Sage Therapeutics (SAGE) report its Q2 2024 financial results?
How can I access Sage Therapeutics' (SAGE) Q2 2024 earnings webcast?
Will there be a replay available for Sage Therapeutics' (SAGE) Q2 2024 earnings webcast?